299
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Pomegranate (Punica granatum) Fruit Extract Suppresses Cancer Progression and Tumor Angiogenesis of Pancreatic and Colon Cancer in Chick Chorioallantoic Membrane Model

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1350-1356 | Received 05 Dec 2019, Accepted 06 Jul 2020, Published online: 06 Aug 2020

References

  • Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921.
  • Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012;51(1):3–13. doi:10.1002/mc.20785
  • Balchen V, Simon K. Colorectal cancer development and advances in screening. Clin Interventions Aging. 2016; 11:967–976. doi:10.2147/CIA.S109285
  • Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
  • Marmé D. Tumor angiogenesis: a key target for cancer therapy. Oncol Res Treat. 2018;41(4):164. doi:10.1159/000488340
  • Melegh Z, Oltean S. Targeting angiogenesis in prostate cancer. IJMS. 2019;20(11):2676. doi:10.3390/ijms20112676
  • Itatani Y, Kawada K, Yamamoto T, Sakai Y. Resistance to antiangiogenic therapy in cancer—alterations to anti-VEGF pathway. Int J Mol Sci. 2018;19(4):1232. doi:10.3390/ijms19041232
  • Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3(6):401–410. doi:10.1038/nrc1093
  • Lieu C, Heymach J, Overman M, Tran H, Kopetz S. Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. Clin Cancer Res. 2011;17(19):6130–6139. doi:10.1158/1078-0432.CCR-11-0659
  • Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem. 2005;16(6):360–367. doi:10.1016/j.jnutbio.2005.01.006
  • Nuñez-Sánchez MA, García-Villalba R, Monedero-Saiz T, García-Talavera NV, Gómez-Sánchez MB, Sánchez-Álvarez C, García-Albert AM, Rodríguez-Gil FJ, Ruiz-Marín M, Pastor-Quirante FA, et al. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res. 2014;58(6):1199–1211. doi:10.1002/mnfr.201300931
  • Zahin M, Ahmad I, Gupta RC, Aqil F. Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts. Biomed Res Int. 2014;2014:1–10. doi:10.1155/2014/467465
  • Turrini E, Ferruzzi L, Fimognari C. Potential effects of pomegranate polyphenols in cancer prevention and therapy. Oxid Med Cell Longev. 2015;2015:938475. doi:10.1155/2015/938475
  • Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP. Preliminary studies on the antiangiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2003;6(2):121–128. doi:10.1023/B:AGEN.0000011802.81320.e4
  • Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, et al. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol. 2008;32(2):475–480. http://www.ncbi.nlm.nih.gov/pubmed/18202771 doi:10.3892/ijo.32.2.475
  • Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, Bojanowski MW, Gingras D, Béliveau R. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 2005;26(4):821–826. doi:10.1093/carcin/bgi024
  • Khan N, Afaq F, Kweon M-H, Kim K, Mukhtar H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res. 2007;67(7):3475–3482. doi:10.1158/0008-5472.CAN-06-3941
  • Basu A, Newman ED, Bryant AL, Lyons TJ, Betts NM. Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study. J Nutr Metab. 2013;2013:1–7. doi:10.1155/2013/708381
  • Yalcin M, Dyskin E, Lansing L, Bharali DJ, Mousa SS, Bridoux A, Hercbergs AH, Lin HY, Davis FB, Glinsky GV, et al. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 2010;95(4):1972–1980. doi:10.1210/jc.2009-1926
  • Deryugina EI, Quigley JP. Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules. Methods Enzymol. 2008;444:21–41. doi:10.1016/S0076-6879(08)02802-4
  • Marcinkiewicz C, Weinreb PH, Calvete JJ, Kisiel DG, Mousa SA, Tuszynski GP, Lobb RR. Obtustatin: a potent selective inhibitor of α1β1 integrin in vitro and angiogenesis in vivo. Cancer Res. 2003;63(9):2020–2023.
  • Bridoux A, Cui H, Dyskin E, Yalcin M, Mousa SA. Semisynthesis and pharmacological activities of tetrac analogs: angiogenesis modulators. Bioorg Med Chem Lett. 2009;19(12):3259–3263. doi:10.1016/j.bmcl.2009.04.094
  • Bielenberg DR, Zetter BR. The contribution of angiogenesis to the process of metastasis. Cancer J. 2015;21(4):267–273. doi:10.1097/PPO.0000000000000138
  • Al-Abd AM, Alamoudi AJ, Abdel-Naim AB, Neamatallah TA, Ashour OM. Antiangiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies—a review. J Adv Res. 2017;8(6):591–605. doi:10.1016/J.JARE.2017.06.006
  • Wang T-Y, Chen J-X. Effects of curcumin on vessel formation insight into the pro- and antiangiogenesis of curcumin. Evid Based Complement Alternat Med. 2019;2019:1390795. doi:10.1155/2019/1390795
  • Adams LS, Zhang Y, Seeram NP, Heber D, Chen S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res. 2010;3(1):108–113. doi:10.1158/1940-6207.CAPR-08-0225
  • Nuñez-Sánchez MA, Dávalos A, González-Sarrías A, Casas-Agustench P, Visioli F, Monedero-Saiz T, García-Talavera NV, Gómez-Sánchez MB, Sánchez-Álvarez C, García-Albert AM, et al. MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: critical issues to discern between modulatory effects and potential artefacts. Mol Nutr Food Res. 2015;59(10):1973–1986. doi:10.1002/mnfr.201500357
  • Nair V, Dai Z, Khan M, Ciolino HP. Pomegranate extract induces cell cycle arrest and alters cellular phenotype of human pancreatic cancer cells. Anticancer Res. 2011;31(9):2699–2704. http://www.ncbi.nlm.nih.gov/pubmed/21868510
  • Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA. 2005;102(41):14813–14818. doi:10.1073/pnas.0505870102
  • Khan N, Hadi N, Afaq F, Syed DN, Kweon M-HH, Mukhtar H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 2007;28(1):163–173. doi:10.1093/carcin/bgl145
  • Liu H, Zeng Z, Wang S, Li T, Mastriani E, Li Q-H, Bao H-X, Zhou Y-J, Wang X, Liu Y, et al. Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9. Cancer Biol Ther. 2017;18(12):990–999. doi:10.1080/15384047.2017.1394542
  • Bishayee A, Bhatia D, Thoppil RJ, Darvesh AS, Nevo E, Lansky EP. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 2011;32(6):888–896. doi:10.1093/carcin/bgr045
  • Vanella L, Di Giacomo C, Acquaviva R, Barbagallo I, Li Volti G, Cardile V, Abraham N, Sorrenti V. Effects of ellagic acid on angiogenic factors in prostate cancer cells. Cancers. 2013;5(4):726–738. doi:10.3390/cancers5020726
  • Ceci C, Tentori L, Atzori M, Lacal P, Bonanno E, Scimeca M, Cicconi R, Mattei M, de Martino M, Vespasiani G, et al. Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth. Nutrients 2016;8(11):744. doi:10.3390/nu8110744
  • Wang N, Wang Z-Y, Mo S-L, Loo TY, Wang D-M, Luo H-B, Yang D-P, Chen Y-L, Shen J-G, Chen J-P, et al. Ellagic acid, a phenolic compound, exerts antiangiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res Treat. 2012;134(3):943–955. doi:10.1007/s10549-012-1977-9
  • Chandler LA, Sosnowski BA, Greenlees L, Aukerman SL, Baird A, Pierce GF. Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. Int J Cancer 1999;81(3):451–458. doi:10.1002/(sici)1097-0215(19990505)81:3 < 451::aid-ijc20 > 3.0.co;2-h
  • Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer. 2004;11:709–724. doi:10.1677/erc.1.00535

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.